APA (7th ed.) Citation

JTD, S. F., LO, C., EQ, C., V, H., & A, M. (2025). Survival impact of anti-CD38-based quadruplet regimens in transplant-ineligible newly diagnosed multiple myeloma: A network meta-analysis and reconstructed individual patient data meta-analysis. Blood cancer journal, 15(1), 212. https://doi.org/10.1038/s41408-025-01413-7

Chicago Style (17th ed.) Citation

JTD, Souto Filho, Cantadori LO, Crusoe EQ, Hungria V, and Maiolino A. "Survival Impact of Anti-CD38-based Quadruplet Regimens in Transplant-ineligible Newly Diagnosed Multiple Myeloma: A Network Meta-analysis and Reconstructed Individual Patient Data Meta-analysis." Blood Cancer Journal 15, no. 1 (2025): 212. https://doi.org/10.1038/s41408-025-01413-7.

MLA (9th ed.) Citation

JTD, Souto Filho, et al. "Survival Impact of Anti-CD38-based Quadruplet Regimens in Transplant-ineligible Newly Diagnosed Multiple Myeloma: A Network Meta-analysis and Reconstructed Individual Patient Data Meta-analysis." Blood Cancer Journal, vol. 15, no. 1, 2025, p. 212, https://doi.org/10.1038/s41408-025-01413-7.